Drug recall · October 7, 2020
Losartan Pot/HCTZ 50/12.5 mg 90 Tabs recall
Why: CGMP deviation: Trace amounts of impurity detected to be N-Methylnitrosobutyric acid (NMBA) in the API.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Pot/HCTZ 50/12.5 mg 90 Tabs Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg For: Torrent Pharma, Inc. Basking Ridge, NJ 07920 NDC 61919-040-90
- Lots / codes
Lot: 12DE1806 Exp. 01/31/2021
- Quantity
- 33 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- FL
- Initiated
- March 12, 2019 · Voluntary: Firm initiated
- Classified
- October 12, 2020
- Reported
- October 7, 2020
- Ended
- September 21, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.